Work

Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism

Year: 2022

Type: article

Source: Drug Metabolism and Disposition

DOI: 10.1124/dmd.122.000929

Authors: Emily J. Koubek, Sarah A. Buhrow, Stephanie L. Safgren, Lee Jia, Matthew P. Goetz, Matthew M. Ames, Joel M. Reid

Institutions: National Institutes of Health, Mayo Clinic

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, Pfizer, AstraZeneca, National Institutes of Health, National Cancer Institute

Awards: G131523128, G3503792436, G386607036, G4630458729, G5888954722, G5920237370, Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents, G844520391, G9000126810, Mayo Clinic Comprehensive Cancer Center Support Grant

OpenAlex ID: W4308686531

FWCI: 0.913

Cites: 41

Cited by: 4

Related to: 10